About Cytosorbents Company
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Princeton, NJ.
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersCytoSorbents (NASDAQ:CTSO) stock rose 17.3% to $1.29 during Friday's pre-market session. The company's market cap stands at $57.3 million. Tonix Pharmaceuticals (NASDAQ:TNXP) stock rose 15.43%
Promising Financial Outlook and Potential Game-Changer Study Drive Buy Rating for Cytosorbents
Cytosorbents GAAP EPS of -$0.21 Misses by $0.09, Revenue of $8.8M Misses by $0.52M